22 results on '"Rönnelid, Johan"'
Search Results
2. Additional file 1 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
3. Additional file 1: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
4. Additional file 2: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
5. Additional file 5 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
6. Additional file 4: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
7. Additional file 9 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
8. Additional file 1 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
9. Additional file 5 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
10. Additional file 2 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
11. Additional file 5: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
12. Additional file 9 of Presence of autoantibodies in 'seronegative' rheumatoid arthritis associates with classical risk factors and high disease activity
13. Additional file 1 of The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual 'window of treatment success' in RA patients
14. Additional file 3: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
15. Additional file 1 of The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual 'window of treatment success' in RA patients
16. Additional file 3: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
17. Additional file 2: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
18. Additional file 6: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
19. Additional file 1: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
20. Additional file 6: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
21. Additional file 4: of Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives
22. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.